To explore the mechanism for Bev resistance, we have conducted comparative analyses of VEGF expression levels, tumor oxygenation, stemness, and immunoregulatory mechanisms using samples from patients that were naïve to, treated with, and refractory to Bev treatment using paired samples obtained from initial and recurrent surgery [3–6]. The gene discussed is VEGFA; the disease is neoplasm.